Picture of Treace Medical Concepts logo

TMCI — Treace Medical Concepts News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Treace Medical Concepts Inc reports results for the quarter ended in June - Earnings Summary

* Treace Medical Concepts Inc  TMCI.OQ  reported a quarterly
adjusted loss of 31 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 20 cents per share.
    * Revenue rose 45.1% to $29.97 million from a year ago;
analysts
expected $28.63 million. 
    * Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Treace Medical Concepts Inc shares had risen by 37.4% this
quarter and gained 5.7% so far this year.
    * The company reported a quarterly loss of $17.23 million.
    * Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $22.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 12:31 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.20          -0.31          Missed
 Mar. 31 2022      -0.20          -0.16          Beat
 Dec. 31 2021      0.00           -0.12          Missed
 Sep. 30 2021      -0.12          -0.12          Met

Recent news on Treace Medical Concepts

See all news